Introduction Torsades de Pointes (TdP) is a potentially lethal polymorphic ventricular tachydysrhythmia associated with and caused by prolonged myocardial repolarization. However, prediction of TdP is challenging. We sought to determine if electrocardiographic myocardial repolarization heterogeneity is necessary and predictive of TdP. Methods We performed a case control study of TdP at a large urban hospital. We identified cases based on a hospital center electrocardiogram (ECG) database search for tracings from 1/2005 to 6/2019 with heart rate corrected QT (QTc) > 500, QRS < 120, and heart rate (HR) < 60, and a subsequent natural language search of electronic health records for the terms: TdP, polymorphic ventricular tachycardia, sudden cardiac death, and relevant variants. Controls were drawn in a 2:1 ratio to cases from a similar pool of ECGs, and matching for QTc, heart rate, sex, and age. We abstracted historical, laboratory, and ECG data using detailed written instructions and an electronic database. We included a second blinded data abstractor to test data abstraction and manual ECG measurement reliability. We used General Electric (GE) QT Guard software for automated repolarization measurements. We compared groups using unpaired statistics. Results We included 75 cases and 150 controls. The number of current QTc prolonging medications and serum electrolytes were substantially the same between the two groups. We found no significant difference in measures of QT or T wave repolarization heterogeneity. Conclusion Electrocardiographic repolarization heterogeneity is not greater in otherwise unselected patients with QTc prolongation who suffer TdP and does not appear predictive of TdP. However, previous observations suggest specific repolarization characteristics may be useful for defined patient subgroups at risk for TdP.
Introduction: Torsades de Pointes (TdP) is a potentially lethal ventricular tachydysrhythmia associated by definition with prolonged myocardial repolarization. However, prolonged myocardial repolarization is not specific for TdP. Our primary objective was to determine if heterogeneous myocardial repolarization manifested by corrected QT (QTc) and T wave variation is necessary and predictive of TdP. Methods: We performed an IRB approved case control study of TdP at a large urban hospital. We identified cases based on a MUSE ECG database search for tracings from 1/05 to 6/19 with QTc>500, QRS<120, and HR<60, and a subsequent natural language search of electronic health records for the terms: TdP, polymorphic ventricular tachycardia, sudden cardiac death, etc. Controls were drawn in a 2:1 ratio to cases from a similar pool of ECGs, and matching for sex, age, QTc, and heartrate. We abstracted historical, laboratory, ECG, and telemetry data using detailed written instructions and an electronic database. Groups were compared using unpaired and paired nonparametric and parametric statistics as appropriate. Results: We included 75 cases and 150 controls. We found no significant difference in measures of QTc or T wave repolarization heterogeneity, QTc prolonging medications, or serum electrolytes between the two groups. However, 35 cases had brief telemetry strips demonstrating TdP and a median of four beats prior to TdP onset. Ectopy was present in 25 (71%) strips prior to TdP. Heartrate in these cases was also 17 beats per minute (BPM) (95% CI 7 to 27) higher at an average 87 BPM just prior to TdP as compared to their index ECG. Conclusions: Repolarization heterogeneity is not greater in patients with QTc prolongation who suffer TdP. It doesn’t appear mechanistically necessary or predictive of TdP. Ventricular ectopy, possibly triggered from early after depolarizations, but not bradycardia, is common before TdP and may be usefully predictive.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.